View Post

Continuous chemotherapy improves outcomes and quality of life in advanced breast cancer

In Clinical Trials by Barbara Jacoby

Source: European Society for Medical Oncology From: eurekalert.org Continuous chemotherapy shows greater benefit in patients with advanced breast cancer by both improving survival and maintaining quality of life compared to intermittent scheduling, according to analyses of the Stop&Go study presented at the ESMO Breast Cancer Congress 2019, 2-4 May, Berlin, Germany. (1,2,3) The phase III study randomised 420 patients with …

View Post

How Searching for a Mutation Can Help Cancer Treatment

In In The News by Barbara Jacoby

From: European Society for Medical Oncology (ESMO) Making the right therapeutic choice based on a tumour’s DNA Individualised therapies that target the specific genetic features of tumours have the potential to transform cancer diagnosis, treatment and care. Several challenges still need to be overcome before these approaches can be widely used in the clinic. Two DNA testing programmes have been implemented in …

View Post

Encouraging Results For Ribociclib In Advanced Breast Cancer

In In The News by Barbara Jacoby

By: Elaine Schattner From: forbes.com At the European Society for Medical Oncology (ESMO) Congress this week, investigators presented data for a new and potentially important drug, ribociclib (Novartis). This oral medication is clearly active in hormone receptor-positive (ER+ or PR+) breast cancer. The findings of the MONALEESA trial were published in the NEJM. The main result is that for the most …